期刊文献+

唑来膦酸治疗恶性肿瘤骨转移疼痛24例 被引量:2

Zoledronic Acid in the Treatment of 24 Cases with Pain of Bone Metastasis
下载PDF
导出
摘要 [目的]评价唑来膦酸注射液治疗恶性肿瘤骨转移疼痛的疗效和安全性。[方法]48例患者随机分为治疗组和对照组,治疗组24例用唑来膦酸4mg加入生理盐水溶液100ml静脉滴注15min,对照组24例用帕米膦酸二钠90mg加入生理盐水溶液500ml静脉滴注4h,两组均一次性给药后连续观察14d。[结果]治疗组有效率79.2%,对照组70.8%,毒副反应分别为46.2%和41.6%,两者差异均无显著性(P>0.05)。[结论]唑来膦酸治疗恶性肿瘤骨转移所致疼痛有良好的止痛效果,且安全性高,使用方便。
机构地区 慈溪中医医院
出处 《肿瘤学杂志》 CAS 2007年第6期489-490,共2页 Journal of Chinese Oncology
  • 相关文献

参考文献6

  • 1Coukell A J, Markham A. Parnidronate: a review of its use in the management of ostcolytic bone metastases, tumourinduced hypercalcaemia and Paget's disease of bone [J]. Drugs Aging, 1998, 12(12):149-168.
  • 2Boby JJ,Clinical reserch update:zoledronate [J]. Cancer, 1997, 15(8 Suppl):1699-1701.
  • 3Rosen LS,David G, Gimon T, et al. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non small cell lung carcinoma and other solid tumors: A randomized, phase Ⅲ doubleblind, placebo-controlled trial[J].Cancer,2004,100(12):2613.
  • 4Diel IJ,Bergner R.Re:Berenson J,Hirschberg R. Safety and convenience of a 15-minute infusion of zoledronic acid[J]. Oncologist, 2005, 10(1):82-83.
  • 5李园,崔慧娟,武晓勤,程志强,谭煌英.唑来膦酸治疗骨转移癌疼痛的临床观察[J].中国肿瘤临床与康复,2006,13(6):571-574. 被引量:3
  • 6于壮,梁军.唑来膦酸注射液治疗恶性肿瘤骨转移疼痛的临床疗效观察[J].临床肿瘤学杂志,2007,12(2):128-130. 被引量:12

二级参考文献15

  • 1赵翌,李颖,白松,高亚杰,刘基巍.唑来膦酸治疗癌症骨转移疼痛临床观察[J].癌症进展,2005,3(4):395-398. 被引量:13
  • 2王洪亚,王子安,吴穷,秦风展.唑来膦酸治疗恶性肿瘤骨转移疼痛20例临床观察[J].解剖与临床,2004,9(4):265-266. 被引量:6
  • 3Pelger RCM,Soerdjbalie-Maikoe V,Hamdy NAT.strategies for management of prostate cancer-related bone pain[J].Drugs Aging,2001,18(12):899-911.
  • 4Rogers MJ,Gordon S,Benford HL,et al.Cellular and molecular mechanisms of action of bisphosphonates[J].Cancer,2000,88(Suppl):2961.
  • 5Berenson JR,Vescio RA,Rosen LS,et al.A phase Ⅰ dose-ranging trial of monthly infusion of zoledronic acid for the treatment of osteolytic bone metastases[J].Clin Cancer Res,2001,7(3):478-485.
  • 6Witter SL,Javeed M,Crispino J,et al.Inhibition of growth of human breast cancer cells lines with the combination of zoledronic acid and a COX-2 inhibitor[J].Eur J Cancer,2001,37(Suppl 6):78.
  • 7Jagdev SP,Coleman RE,Shipman CM,et al.The bisphosphonate,zoledronic acid,induces apoptosis of breast cancer cells:evidence for synergy with paclitaxel[J].Br J Cancer,2001,84(8):1126-1134.
  • 8Rosen L,Gordon D,Tchekmedyian S,et al.Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors:a phase Ⅲ,double-blind,randomized trial.The Zoledronic Acid Lung Cancer and Other Solid Tumor Study Group[J].Clin Oncol,2003,21:3150.
  • 9Lipton A,Small E,Saad F,et al.The new bisphosphonate,zometa,decreases skeletal complication in both osteolytic and osteoblastic lesions:a comparison to pamidronate[J].Cancer Invest,2002,20(Suppl 2):45-54.
  • 10Kohno N,Agin K,Minami H,et al.Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer:a randomized,placebo-controlled trial[J].Clin Oncol,2005,23(15):3314-3321.

共引文献12

同被引文献34

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部